Nature Communications (Apr 2024)
TAD boundary deletion causes PITX2-related cardiac electrical and structural defects
- Manon Baudic,
- Hiroshige Murata,
- Fernanda M. Bosada,
- Uirá Souto Melo,
- Takanori Aizawa,
- Pierre Lindenbaum,
- Lieve E. van der Maarel,
- Amaury Guedon,
- Estelle Baron,
- Enora Fremy,
- Adrien Foucal,
- Taisuke Ishikawa,
- Hiroya Ushinohama,
- Sean J. Jurgens,
- Seung Hoan Choi,
- Florence Kyndt,
- Solena Le Scouarnec,
- Vincent Wakker,
- Aurélie Thollet,
- Annabelle Rajalu,
- Tadashi Takaki,
- Seiko Ohno,
- Wataru Shimizu,
- Minoru Horie,
- Takeshi Kimura,
- Patrick T. Ellinor,
- Florence Petit,
- Yves Dulac,
- Paul Bru,
- Anne Boland,
- Jean-François Deleuze,
- Richard Redon,
- Hervé Le Marec,
- Thierry Le Tourneau,
- Jean-Baptiste Gourraud,
- Yoshinori Yoshida,
- Naomasa Makita,
- Claude Vieyres,
- Takeru Makiyama,
- Stephan Mundlos,
- Vincent M. Christoffels,
- Vincent Probst,
- Jean-Jacques Schott,
- Julien Barc
Affiliations
- Manon Baudic
- Nantes Université, CHU Nantes, CNRS, INSERM, l’institut du Thorax
- Hiroshige Murata
- The Department of Cardiovascular Medicine, Nippon Medical School Hospital
- Fernanda M. Bosada
- Department of Medical Biology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, University of Amsterdam
- Uirá Souto Melo
- Max Planck Institute for Molecular Genetics, RG Development and Disease
- Takanori Aizawa
- Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine
- Pierre Lindenbaum
- Nantes Université, CHU Nantes, CNRS, INSERM, l’institut du Thorax
- Lieve E. van der Maarel
- Department of Medical Biology, Amsterdam Cardiovascular Sciences, Amsterdam Reproduction and Development, Amsterdam University Medical Centers, University of Amsterdam
- Amaury Guedon
- Nantes Université, CHU Nantes, CNRS, INSERM, l’institut du Thorax
- Estelle Baron
- Nantes Université, CHU Nantes, CNRS, INSERM, l’institut du Thorax
- Enora Fremy
- Nantes Université, CHU Nantes, CNRS, INSERM, l’institut du Thorax
- Adrien Foucal
- Nantes Université, CHU Nantes, CNRS, INSERM, l’institut du Thorax
- Taisuke Ishikawa
- Omics Research Center, National Cerebral and Cardiovascular Center
- Hiroya Ushinohama
- Department of Cardiology, Fukuoka Children’s Hospital
- Sean J. Jurgens
- Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard
- Seung Hoan Choi
- Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard
- Florence Kyndt
- Nantes Université, CHU Nantes, CNRS, INSERM, l’institut du Thorax
- Solena Le Scouarnec
- Nantes Université, CHU Nantes, CNRS, INSERM, l’institut du Thorax
- Vincent Wakker
- Department of Medical Biology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, University of Amsterdam
- Aurélie Thollet
- Nantes Université, CHU Nantes, CNRS, INSERM, l’institut du Thorax
- Annabelle Rajalu
- Nantes Université, CHU Nantes, CNRS, INSERM, l’institut du Thorax
- Tadashi Takaki
- Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application, Kyoto University
- Seiko Ohno
- Department of Bioscience and Genetics, National Cerebral and Cardiovascular Center Research Institute
- Wataru Shimizu
- The Department of Cardiovascular Medicine, Nippon Medical School Hospital
- Minoru Horie
- Department of Cardiovascular Medicine, Shiga University of Medical Science
- Takeshi Kimura
- Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine
- Patrick T. Ellinor
- Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard
- Florence Petit
- Service de Génétique Clinique, CHU Lille, Hôpital Jeanne de Flandre
- Yves Dulac
- Unité de Cardiologie Pédiatrique, Hôpital des Enfants
- Paul Bru
- Service de Cardiologie, GH La Rochelle
- Anne Boland
- Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine (CNRGH)
- Jean-François Deleuze
- Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine (CNRGH)
- Richard Redon
- Nantes Université, CHU Nantes, CNRS, INSERM, l’institut du Thorax
- Hervé Le Marec
- Nantes Université, CHU Nantes, CNRS, INSERM, l’institut du Thorax
- Thierry Le Tourneau
- Nantes Université, CHU Nantes, CNRS, INSERM, l’institut du Thorax
- Jean-Baptiste Gourraud
- Nantes Université, CHU Nantes, CNRS, INSERM, l’institut du Thorax
- Yoshinori Yoshida
- Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application, Kyoto University
- Naomasa Makita
- Omics Research Center, National Cerebral and Cardiovascular Center
- Claude Vieyres
- Cabinet Cardiologique, Clinique St. Joseph
- Takeru Makiyama
- Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine
- Stephan Mundlos
- Max Planck Institute for Molecular Genetics, RG Development and Disease
- Vincent M. Christoffels
- Department of Medical Biology, Amsterdam Cardiovascular Sciences, Amsterdam Reproduction and Development, Amsterdam University Medical Centers, University of Amsterdam
- Vincent Probst
- Nantes Université, CHU Nantes, CNRS, INSERM, l’institut du Thorax
- Jean-Jacques Schott
- Nantes Université, CHU Nantes, CNRS, INSERM, l’institut du Thorax
- Julien Barc
- Nantes Université, CHU Nantes, CNRS, INSERM, l’institut du Thorax
- DOI
- https://doi.org/10.1038/s41467-024-47739-x
- Journal volume & issue
-
Vol. 15,
no. 1
pp. 1 – 15
Abstract
Abstract While 3D chromatin organization in topologically associating domains (TADs) and loops mediating regulatory element-promoter interactions is crucial for tissue-specific gene regulation, the extent of their involvement in human Mendelian disease is largely unknown. Here, we identify 7 families presenting a new cardiac entity associated with a heterozygous deletion of 2 CTCF binding sites on 4q25, inducing TAD fusion and chromatin conformation remodeling. The CTCF binding sites are located in a gene desert at 1 Mb from the Paired-like homeodomain transcription factor 2 gene (PITX2). By introducing the ortholog of the human deletion in the mouse genome, we recapitulate the patient phenotype and characterize an opposite dysregulation of PITX2 expression in the sinoatrial node (ectopic activation) and ventricle (reduction), respectively. Chromatin conformation assay performed in human induced pluripotent stem cell-derived cardiomyocytes harboring the minimal deletion identified in family#1 reveals a conformation remodeling and fusion of TADs. We conclude that TAD remodeling mediated by deletion of CTCF binding sites causes a new autosomal dominant Mendelian cardiac disorder.